Download the White Paper:
Accelerate Clinical Trial Timelines
See how leading organizations use AI and real-world data to streamline study design, reduce delays, and bring therapies to patients faster
Clinical trials are becoming increasingly complex, with growing pressure to reduce timelines, improve precision, and reach the right patients faster. Leveraging real-world data and AI can help teams design smarter studies, identify higher-performing sites, and improve enrollment outcomes.
To explore these approaches in more detail, this white paper outlines how leading organizations are accelerating clinical development. In this white paper, you’ll learn how to:
- Reduce clinical trial timelines by up to 10–20 months
- Improve study design using real-world data and AI
- Identify higher-performing sites and reduce delays
- Optimize patient recruitment and enrollment forecasting
ConcertAI's Precision Trials™
Power clinical trial success with AI-driven design, predictive site selection, and real-world patient insights.
What is PrecisionTrials™?
+
PrecisionTrials™ is ConcertAI’s SaaS solution that combines real-world data with agentic and generative AI to optimize clinical trial design, site strategy, and patient recruitment forecasting.
How does PrecisionTrials™ improve trial design?
+
It enables AI-driven cohort definition and simulation of study outcomes, helping teams refine inclusion/exclusion criteria and forecast enrollment before launch.
Can PrecisionTrials™ enhance patient recruitment?
+
Yes — it uses near real-time oncology real-world data and predictive models to identify eligible patients and reduce screen failure rates, accelerating enrollment.
How does PrecisionTrials™ support site selection?
+
The platform recommends optimal trial sites based on historical performance, patient volume, and diversity goals, reducing non-productive sites and improving per-patient operational efficiency.
What value does PrecisionTrials™ deliver to timelines and costs?
+
PrecisionTrials™ helps cut unplanned study amendments by up to 50%, eliminate months of amendment-related delays, and shorten overall trial timelines — accelerating time to commercial launch.
Who benefits most from PrecisionTrials™?
+
Clinical Development and Clinical Operations teams benefit significantly — from eligibility criteria planning and feasibility validation to efficient execution and site strategy optimization.